Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|March 27, 2002
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancerEdgardo Rivera, Vicente Valero, Francisco J Esteva, et al.Cellular Signalling|April 20, 2004
Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activityAfshin Ghavami, Rachel A Hunt, Michael A Olsen, et al.Brain Research|March 7, 2008
Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxineZia Rahman, Robert H Ring, Kimberly Young, et al.Journal of Affective Disorders|January 8, 2013
Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episodeLakshmi N Yatham, Konstantinos N Fountoulakis, Zia Rahman, et al.Journal of Affective Disorders|December 25, 2012
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigineDavid E Kemp, Marc De Hert, Zia Rahman, et al.Gynecologic Oncology|October 15, 2014
A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group StudyDon S Dizon, Michael W Sill, Jeanne M Schilder, et al.Psychopharmacology|January 19, 2006
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implicationsRobert H Ring, Jessica E Malberg, Lisa Potestio, et al.Biological Psychiatry|November 17, 2009
Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesiaMing-Hi Han, Willam Renthal, Robert H Ring, et al.Pharmacology & Therapeutics|October 3, 2006
Differentiating antidepressants of the future: efficacy and safetySharon Rosenzweig-Lipson, Chad E Beyer, Zoë A Hughes, et al.CNS Spectrums|March 20, 2014
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapyJ Craig Nelson, Zia Rahman, Kimberly K Laubmeier, et al.Pageof 4